DUBLIN--(BUSINESS WIRE)--The "Indian Vaccine Market Report and Forecast 2017-2022" report has been added to Research and Markets' offering.
Over the years, India has emerged as one of the leading manufacturers of vaccines worldwide, and supplies large quantities of basic and advanced vaccines to nearly 150 countries. Currently, around 70% of the total volume of the vaccines manufactured is exported while the rest is utilised domestically. According to Indian Vaccine Market Report and Forecast 2017-2022, the Indian vaccine market reached a value of around INR 59 Billion in 2016, growing at a CAGR of nearly 18% during 2009-2016.
The strong growth of the market can be attributed to numerous favourable factors. One of the primary forces that is stimulating the market growth is the increasing investments in research and development (R&D) by government funding agencies like the Department of Biotechnology, the Indian Council of Medical Research, and the Ministry of Health and Family Welfare.
The launch of the Universal Immunization Program (UIP) aimed at increased immunization coverage against vaccine preventable diseases in the country has also significantly added to the market growth. Moreover, with advancement in technology, the vaccine production capacity along with cold chain storage facilities have also been improved.
Besides this, the advent of a number of privately owned firms in India have positively transformed the industry. These firms have been making efforts to bring low-cost solutions and are increasingly shifting their focus on innovation so as to increase their revenues. Owing to these factors, India has emerged as a global vaccine manufacturing hub.
The report has segmented the Indian vaccine market on the basis of vaccine type. Currently, oral polio vaccine accounts for the majority of the market share, followed by rabies vaccines. The report has also analysed the competitive landscape and provides the profiles of the key players operating in the market.
Some of the major players include Sanofi Aventis, Pfizer, Novartis, Serum Institute and Panacea Biotech.
Key Vaccines Covered in the Report:
- BCG
- HIB
- Influenza
- Varicella
- Typhoid
- Japanese Encephalitis
- Measles
- Tetanus Toxoid
- Hepatitis A
- Rubella
- DPT
- Polio
- MMR
- Rotavirus
- Hepatitis B
- Pneumococcal
- Meningococcal
- Rabies
- HPV
Focus of the Analysis for Each Vaccine:
- Vaccine Overview
- Historical and Current Market Trends
- Market Breakup by Prescriber
- Market Breakup by Public and Private Sector
- Market Outlook
Key Player Profiles
- GlaxoSmithKline
- Sanofi Aventis
- Pfizer
- Novartis
- Serum Institute of India
- Panacea Biotech
- VHB Lifesciences
- Zydus Cadila
- MSD
-
Shantha Biotech
For more information about this report visit https://www.researchandmarkets.com/research/b6zl58/indian_vaccine
